ECON2023
EVENT

Registration & Coffee

Redefining Monitoring: The Future of Clinical Monitoring in an AI-Enabled World

This opening keynote will set the stage for the conference by examining how emerging technologies are changing the way CRAs monitor trials, and what this means for oversight, accountability, and the evolving role of the CRA.

CRA Oversight in Modern Clinical Trials

As clinical trials become more complex and distributed, the role of CRA oversight is evolving. In this session, Sergio Rodríguez de Rivera Garrido, Associate Director, Clinical Operations at KCR, an ICON Plc company, will explore what effective oversight looks like today, how CRAs can add real value beyond checklists, and where judgment, risk awareness, and collaboration matter most in modern monitoring.